Acute Gout Management
Initial Treatment
- For a patient with acute gout, the American College of Rheumatology recommends prescribing a 5-10 day course of oral prednisone at 0.5 mg/kg per day until complete resolution of symptoms, with high-quality evidence supporting its use 1
- Alternative regimen: 2-5 days at full dose followed by tapering for 7-10 days can be considered 1
- Colchicine can be continued at 0.6 mg once or twice daily until the attack completely resolves, as it is most effective when started within 36 hours of symptom onset, but can still provide benefit as continuation therapy 1
Combination Therapy
- If inadequate response is observed (defined as <20% improvement in pain within 24 hours or <50% improvement after 24 hours), consider adding an NSAID (if no contraindications) along with colchicine 1
- Alternatively, increase prednisone dose if NSAIDs are contraindicated 1
- Intra-articular corticosteroid injection can provide rapid relief and is a consideration for patients with inadequate response 1
Oral Corticosteroids
- Oral corticosteroids are recommended as first-line therapy for acute gout due to their effectiveness comparable to NSAIDs but with fewer adverse effects 2
- The American College of Rheumatology guidelines strongly support using prednisone at 0.5 mg/kg per day for 5-10 days, with high-quality evidence supporting its use 1
Urate-Lowering Therapy
- After resolution of the acute attack, consider urate-lowering therapy (e.g., allopurinol) for patients with recurrent episodes, such as this patient's third episode 1
- If initiating urate-lowering therapy, continue prophylaxis with low-dose colchicine (0.6 mg once or twice daily) or low-dose prednisone (<10 mg/day) for at least 6 months 1
Monitoring and Prevention
- Assess response to treatment within 24-48 hours and monitor for potential corticosteroid side effects 1
- Consider checking renal function if prolonged NSAID or colchicine use is anticipated, and adjust colchicine dosing if renal impairment is present 1
- Provide written instructions on the tapering schedule if applicable and ensure the patient understands the correct dosing regimen to prevent future confusion 1